224 related articles for article (PubMed ID: 30132554)
21. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
23. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
Wang W; Bo H; Liang Y; Li G
Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
[TBL] [Abstract][Full Text] [Related]
24. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
25. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.
He RQ; Gao L; Ma J; Li ZY; Hu XH; Chen G
Oncol Rep; 2018 Jul; 40(1):83-100. PubMed ID: 29749535
[TBL] [Abstract][Full Text] [Related]
27. PRDM16 functions as a suppressor of lung adenocarcinoma metastasis.
Fei LR; Huang WJ; Wang Y; Lei L; Li ZH; Zheng YW; Wang Z; Yang MQ; Liu CC; Xu HT
J Exp Clin Cancer Res; 2019 Jan; 38(1):35. PubMed ID: 30683132
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of LINC00982 inhibits cell proliferation and promotes cell apoptosis by regulating the activity of PI3K/AKT signaling pathway in renal cancer.
Zhang C; Li XY; Luo ZZ; Wu TW; Hu H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1443-1450. PubMed ID: 30840265
[TBL] [Abstract][Full Text] [Related]
29. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma.
Qiu M; Feng D; Zhang H; Xia W; Xu Y; Wang J; Dong G; Zhang Y; Yin R; Xu L
Oncotarget; 2016 Mar; 7(13):16012-22. PubMed ID: 26918601
[TBL] [Abstract][Full Text] [Related]
31. The upregulation of TMPRSS4, partly ascribed to the downregulation of miR‑125a‑5p, promotes the growth of human lung adenocarcinoma via the NF‑κB signaling pathway.
Fan X; Liang Y; Liu Y; Bai Y; Yang C; Xu S
Int J Oncol; 2018 Jul; 53(1):148-158. PubMed ID: 29750426
[TBL] [Abstract][Full Text] [Related]
32. Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
Jung J; Lee YJ; Kim CH; Ahn S
PLoS One; 2021; 16(3):e0247928. PubMed ID: 33684161
[TBL] [Abstract][Full Text] [Related]
33. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
Zhong M; Jiang Q; Jin R
IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
[TBL] [Abstract][Full Text] [Related]
34. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
36. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
[TBL] [Abstract][Full Text] [Related]
37. NFIX downregulation independently predicts poor prognosis in lung adenocarcinoma, but not in squamous cell carcinoma.
Ge J; Dong H; Yang Y; Liu B; Zheng M; Cheng Q; Peng L; Li J
Future Oncol; 2018 Dec; 14(30):3135-3144. PubMed ID: 30418046
[TBL] [Abstract][Full Text] [Related]
38. Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression.
Malvi P; Janostiak R; Nagarajan A; Cai G; Wajapeyee N
PLoS Genet; 2019 Oct; 15(10):e1008439. PubMed ID: 31589613
[TBL] [Abstract][Full Text] [Related]
39. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Li J; Yu X; Liu Q; Ou S; Li K; Kong Y; Liu H; Ouyang Y; Xu R
Mol Med Rep; 2019 May; 19(5):4067-4080. PubMed ID: 30896819
[TBL] [Abstract][Full Text] [Related]
40. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
